Peripheral nerve disorders represent a vast and often debilitating category of neurological disease, encompassing conditions from common compressive entrapments like carpal tunnel syndrome to rare inherited neuropathies and traumatic injuries. Historically, diagnosing these disorders relied heavily upon clinical examination and electrodiagnostic testing, which, while useful, offer limited anatomical insight into the precise location, extent, and nature of nerve pathology. Magnetic resonance imaging (MRI) has emerged as a transformative tool, providing radiologists and neurologists with non-invasive, high-resolution visualization of peripheral nerves and their surrounding soft tissues. This ability to directly image nerve structure, detect subtle pathological changes, and guide treatment planning has fundamentally enhanced the diagnostic workup and management of peripheral nerve disease.

Understanding Peripheral Nerve Disorders: A Clinical Challenge

Peripheral nerves form an intricate network connecting the central nervous system to muscles, skin, and organs, transmitting motor and sensory signals essential for daily function. When these nerves become damaged or diseased, patients may experience pain, numbness, weakness, atrophy, or autonomic dysfunction. The causes are diverse: mechanical compression or entrapment, trauma with laceration or stretch injury, inflammatory and autoimmune conditions, metabolic diseases such as diabetes, toxic exposure, hereditary disorders, and neoplastic processes. The clinical presentation often overlaps between etiologies, and symptoms can be vague or migrate over time, making accurate diagnosis difficult without advanced imaging.

Diagnostic delay is common in peripheral nerve disorders. A patient with an atypical ulnar neuropathy at the elbow may be misdiagnosed as having a cervical radiculopathy. Similarly, an early inflammatory neuropathy such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can mimic other conditions. Without a clear anatomical roadmap of the affected nerve, clinicians must rely on indirect functional measurements. MRI closes this gap by providing a direct view of the nerve itself, its fascicular architecture, caliber, signal intensity, and relationship to adjacent structures such as bones, ligaments, muscles, and blood vessels.

Traditional Diagnostic Methods and Their Limitations

Clinical Examination and Electrodiagnostic Testing

For decades, the cornerstone of peripheral nerve diagnosis has been the clinical neurologic examination complemented by nerve conduction studies (NCS) and electromyography (EMG). NCS measures the velocity and amplitude of electrical impulses along a nerve, while EMG assesses the electrical activity of muscle fibers innervated by that nerve. These tests can confirm the presence of neuropathy, localize conduction abnormalities, and distinguish between demyelinating and axonal injury patterns. However, they have significant limitations. They cannot visualize the nerve directly, so they provide no information about the precise morphology of the lesion, such as whether a nerve is compressed by a ganglion cyst, encased in scar tissue, or interrupted by a transection. They also have poor sensitivity for certain pathologies, particularly inflammatory processes and tumors, and can be technically challenging or painful for the patient.

Ultrasound as a Complementary Tool

High-resolution ultrasound (US) has gained traction in peripheral nerve imaging because it is readily available, inexpensive, and dynamic, allowing real-time assessment during limb movement. It can detect changes in nerve cross-sectional area, echotexture, and vascularity. Carpal tunnel syndrome, for instance, is commonly assessed with ultrasound measurements of the median nerve. Nevertheless, ultrasound has drawbacks: operator dependence, limited field of view, difficulty visualizing deep nerves (e.g., the sciatic nerve in the thigh or the brachial plexus components deep within the neck), and inability to image through bone or air. These constraints often necessitate confirmatory or adjunctive MRI, especially when anatomy is complex or pathology is subtle.

How MRI Overcomes Diagnostic Gaps

MRI possesses intrinsic advantages that address many of the shortcomings of electrodiagnostic testing and ultrasound. Its superior soft tissue contrast, multiplanar capability, and ability to acquire multiple tissue contrasts (T1-weighted, T2-weighted, STIR, DTI, etc.) allow comprehensive characterization of peripheral nerves from their roots at the spinal cord to their distal branches.

High-Resolution Soft Tissue Contrast

The peripheral nerve is a complex structure consisting of the epineurium (outer sheath), perineurium (fascicular boundary), and endoneurium (inner connective tissue). Normal nerves appear isointense to muscle on T1-weighted images and mildly hyperintense on T2-weighted sequences. The use of fat-suppression techniques, particularly short tau inversion recovery (STIR) sequences, markedly increases the conspicuity of nerve pathology by suppressing the high signal from surrounding fat, rendering inflamed or edematous nerves as bright, easily identifiable structures. This allows detection of subtle abnormalities such as fascicular enlargement, perineural edema, or wallerian degeneration that would be invisible on other modalities.

Non-Invasive and No Ionizing Radiation

MRI is a purely non-invasive technique that does not expose the patient to ionizing radiation. This is especially important for patients who may require serial imaging to monitor disease progression or response to therapy, such as those with chronic inflammatory neuropathies or after nerve repair surgery. It also makes MRI safe in pediatric populations and in young adults who may need repeated studies over a lifetime. The absence of radiation risk is a significant advantage over CT scans, which are sometimes used to evaluate bony impingement or tumors affecting nerves.

Whole-Body and Multiparametric Assessment

Modern MRI systems with large bore sizes and dedicated coil arrays can image the peripheral nervous system from the neck to the foot. This is essential for diffuse or multifocal conditions like hereditary neuropathy with liability to pressure palsies (HNPP) or CIDP. Additionally, MRI can acquire multiple pulse sequences in a single session, providing complementary information. For example, T1-weighted images show nerve morphology and anatomy, T2-weighted with fat suppression highlights edema and inflammation, and post-contrast T1-weighted images can identify disruption of the blood-nerve barrier (seen in inflammatory and neoplastic conditions). This multiparametric approach yields a comprehensive picture of nerve health that no single test can offer.

Specific MRI Techniques for Peripheral Nerves

Conventional MRI Protocols

Standard peripheral nerve MRI protocols typically include axial and coronal T1-weighted and T2-weighted sequences with fat suppression, as well as STIR images through the region of interest. For the brachial plexus, coronal STIR and coronal T1-weighted sequences are routine; for the lumbosacral plexus, sagittal and axial views of the lumbar spine combined with plexus-specific sequences. These conventional techniques can identify nerve compression, discontinuity, neuroma formation, and enlargement. They are widely available and well-established in clinical practice.

MR Neurography

MR neurography (MRN) is a specialized refinement of conventional MRI that optimizes pulse sequences and coil selection to maximize the signal-to-noise ratio from peripheral nerves. It typically employs a three-dimensional (3D) STIR or T2-weighted sequence with isotropic voxels, allowing reconstruction in any plane. MRN can also incorporate diffusion-weighted imaging (DWI) to exploit the diffusion properties of water within the nerve. The result is striking, detailed delineation of nerve fascicles, often with a “salt-and-pepper” appearance on axial images due to the alternating signal intensity of nerve bundles and internal connective tissue. MRN is particularly effective for detecting subtle fascicular abnormalities, such as enlargement, discontinuity, or torsion, that can be missed on routine sequences.

Diffusion Tensor Imaging and Tractography

Diffusion tensor imaging (DTI) is a more advanced MRI technique that measures the directional diffusion of water molecules. In a healthy nerve, water diffusion is highly anisotropic – it moves preferentially along the long axis of the nerve fibers due to the restrictive boundaries of myelin sheaths and axonal membranes. When a nerve is damaged – whether by demyelination, axonal loss, or Wallerian degeneration – this anisotropic diffusion is disrupted. DTI metrics such as fractional anisotropy (FA) and mean diffusivity (MD) can quantitatively reflect nerve integrity. DTI-based tractography can reconstruct the three-dimensional course of nerve fibers, which is valuable for preoperative planning in complex tumors or trauma cases, and for assessing regeneration after nerve repair. Several studies have demonstrated that FA values correlate well with functional recovery in conditions like carpal tunnel syndrome and traumatic nerve injury.

Dynamic and Contrast-Enhanced MRI

Dynamic contrast-enhanced MRI (DCE-MRI) can evaluate the microvascular permeability and perfusion of the blood-nerve barrier. In inflammatory neuropathies (e.g., Guillain‑Barré syndrome, CIDP, vasculitic neuropathy), the blood-nerve barrier is disrupted, leading to abnormal enhancement after intravenous gadolinium administration. This enhancement can be focal or diffuse, and it often correlates with clinical severity. DCE-MRI can also differentiate nerve tumors: benign schwannomas and neurofibromas typically show avid, heterogeneous enhancement, while malignant peripheral nerve sheath tumors (MPNSTs) may demonstrate more irregular enhancement patterns and rapid washout. Dynamic MRI protocols that capture multiple time points after contrast injection provide additional kinetic information useful for lesion characterization.

Clinical Applications and Diagnosable Conditions

Entrapment Neuropathies

Entrapment neuropathies – such as carpal tunnel syndrome (median nerve at the wrist), cubital tunnel syndrome (ulnar nerve at the elbow), and tarsal tunnel syndrome (tibial nerve at the ankle) – are among the most common indications for peripheral nerve MRI. MRI can directly visualize compression of the nerve by surrounding structures like the transverse carpal ligament, the flexor retinaculum, or a ganglion cyst. Signs of entrapment include nerve enlargement proximal to the compression, flattening at the compression site, increased T2 signal from intraneural edema, and fascicular blurring. This imaging data can confirm the diagnosis, grade severity, and guide surgical decompression by pinpointing the exact site of impingement.

Traumatic Nerve Injury

Traumatic injuries to peripheral nerves, such as brachial plexus avulsion, laceration, or stretch injury, are common after motor vehicle accidents, falls, or penetrating trauma. MRI can differentiate between neuropraxia (mild compression with intact nerve continuity), axonotmesis (disruption of axons with intact endoneurial tubes), and neurotmesis (complete nerve transection). This distinction is critical for prognosis and treatment – neurotmesis usually requires surgical repair, while neuropraxia may recover spontaneously. MR neurography and DTI tractography can assess the viability of proximal and distal nerve stumps, identify a gap for nerve grafting, and detect neuroma formation. Postoperative imaging can evaluate the integrity of nerve grafts and the progression of axonal regeneration. Recent reviews highlight the growing role of MRI in traumatic nerve injury management.

Inflammatory and Autoimmune Neuropathies

Inflammatory neuropathies represent a spectrum from acute inflammatory demyelinating polyneuropathy (AIDP, the classic Guillain‑Barré syndrome) to chronic forms such as CIDP and multifocal motor neuropathy (MMN). MRI shows characteristic findings including diffuse or multifocal nerve enlargement, increased T2 signal, and contrast enhancement reflecting blood-nerve barrier breakdown. In CIDP, the roots of the brachial and lumbosacral plexuses often appear thickened and hyperintense. MRI can also help distinguish between demyelinating and axonal forms, guide nerve biopsy location, and monitor response to immunosuppressive therapy. A 2022 consensus statement by the Peripheral Nerve Society recommended MRI as part of the diagnostic workup for suspected CIDP.

Peripheral Nerve Tumors and Tumor-Like Lesions

Both benign (schwannoma, neurofibroma, perineurioma) and malignant (MPNST) peripheral nerve sheath tumors are well-evaluated with MRI. Benign schwannomas appear as well-circumscribed, fusiform masses arising eccentrically from the nerve, often with a classic “target sign” on T2-weighted images (a central low-signal area within a high-signal periphery). Neurofibromas, in contrast, are typically more central and may be multiple in neurofibromatosis type 1. Malignant transformation is suspected when a known benign nerve tumor shows rapid growth, irregular margins, heterogeneous enhancement, and perilesional edema. MRI features that help differentiate MPNST from benign tumors include larger size (>5 cm), incomplete pseudocapsule, intratumoral necrosis, and peritumoral edema. Advanced sequences like DWI and perfusion-weighted imaging can further improve diagnostic confidence. The FDA provides safety guidance for MRI in patients with implanted devices, which is relevant for some tumor biopsy cases.

Hereditary Neuropathies

Charcot‑Marie‑Tooth disease (CMT) and other hereditary neuropathies are genetic disorders that lead to progressive nerve degeneration. MRI of the lower legs can identify characteristic patterns of fatty atrophy in denervated muscles, such as anterolateral compartment involvement in CMT1A and diffuse involvement in CMTX. In the brachial plexus, MRI may show diffuse nerve thickening in demyelinating subtypes. While genetic testing remains the gold standard for diagnosis, MRI can provide supportive evidence and help exclude acquired mimics. Research is ongoing to develop quantitative MRI biomarkers for disease progression that could serve as surrogate endpoints in clinical trials. A 2020 study demonstrated that DTI-derived FA values in the sciatic nerve correlate with clinical severity scores in CMT.

Advantages Over Other Imaging Modalities

Compared to ultrasound, MRI offers a larger field of view, better soft tissue contrast, and less operator dependency. It can visualize deep nerves that are inaccessible to ultrasound (e.g., lumbar plexus in obese patients, sub-clavian portion of brachial plexus). Compared to CT, MRI provides superior nerve-tissue contrast without ionizing radiation. CT is sometimes used for preoperative evaluation of bone anomalies or calcified masses compressing a nerve, but it cannot directly show nerve pathology. Positron emission tomography (PET) with FDG can be useful for detecting metabolically active tumors or inflammation, but it lacks anatomical detail; combined PET/MRI is emerging as a powerful hybrid technique that marries the metabolic sensitivity of PET with the structural resolution of MRI. Overall, MRI is the most comprehensive single imaging modality for evaluating peripheral nerve disorders.

Challenges and Limitations of MRI

Despite its many advantages, MRI for peripheral nerve imaging is not without challenges. The examinations are more expensive and less widely available than nerve conduction studies or ultrasound. They also require specialized knowledge: not all radiologists are experienced in interpreting peripheral nerve anatomy and pathology. The use of dedicated surface coils (e.g., wrist coils for carpal tunnel, knee coils for the common peroneal nerve at the fibular head) improves image quality but adds complexity to scan set-up. Patient motion can degrade image quality, particularly for diffusion sequences that are sensitive to bulk movement. Claustrophobia, metal implants, and cardiac pacemakers may preclude MRI or require careful safety screening. Finally, the clinical significance of some MRI findings, such as mild T2 hyperintensity in an asymptomatic nerve, is not always clear; correlation with electrodiagnostic and clinical data remains essential to avoid overdiagnosis.

Future Directions and Emerging Research

Quantitative MRI

Advances in quantitative MRI are moving beyond qualitative signal assessment toward objective, reproducible metrics. T2 mapping measures the relaxation time constant T2 in tissue, which increases in edematous or demyelinated nerves. Diffusion kurtosis imaging (DKI) extends DTI by modeling the non-Gaussian diffusion of water, potentially providing more specific information about tissue microstructure. Magnetization transfer ratio (MTR) imaging reflects the amount of myelin and can detect demyelination. These techniques are being validated in clinical studies and may eventually provide surrogate markers for disease severity and treatment response in clinical trials.

Artificial Intelligence and Radiomics

Machine learning algorithms, particularly deep learning convolutional neural networks, are being trained to automatically segment peripheral nerves, detect pathology, and even predict prognosis from MRI data. Radiomics – the extraction of hundreds of quantitative features from medical images – can uncover patterns invisible to the human eye. Early work on nerve tumors and entrapment neuropathies suggests that AI-assisted analysis can improve diagnostic accuracy and reduce interpretation time. Integration of AI into clinical MRI workflows may become routine within the next decade.

Combined PET/MRI

Simultaneous PET/MRI scanners are now available at major academic centers. For peripheral nerve imaging, PET can add metabolic information, for example, increased FDG uptake in malignant nerve tumors or active inflammatory foci in vasculitic neuropathy. The combination of high-resolution MRI with metabolic data could improve the characterization of indeterminate nerve lesions and detect occult neuropathies. As PET tracers become more specific (e.g., myelin-targeting agents, markers of neuroinflammation), the role of PET/MRI in neurology is likely to expand.

Functional Evaluation and Beyond

Although still largely experimental, functional MRI (fMRI) of peripheral nerves has been attempted by applying electrical or mechanical stimulation and detecting BOLD signal changes in the nerve itself or in the spinal dorsal horn. This could one day provide a direct measure of nerve function and response to therapy. Meanwhile, diffusion tensor imaging of the brachial plexus is already aiding surgical planning for nerve transfer procedures. Future innovations may include ultra-high-field imaging (7T and beyond) for even higher resolution of nerve fascicles, and the use of contrast agents that target specific receptors on peripheral nerves (e.g., nerve-specific gadolinium chelates).

Conclusion

Magnetic resonance imaging has fundamentally enhanced the diagnosis and management of peripheral nerve disorders. Its unparalleled ability to visualize the morphology, pathology, and integrity of nerves offers a level of anatomical and tissue characterization that no other diagnostic tool can match. From common entrapments to complex traumatic and inflammatory conditions, MRI provides clinicians with a clear road map to guide both diagnosis and intervention. While challenges in cost, accessibility, and interpretation remain, ongoing advances in pulse sequences, quantitative imaging, and artificial intelligence promise to further broaden its clinical utility. As the field of peripheral nerve imaging continues to mature, MRI will undoubtedly play an ever more central role in delivering personalized, precise care to patients suffering from these often disabling diseases.